Z-0820-2021 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-0820-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 7, 2020 and is designated Class II. Reason for recall: The sodium and/or calcium levels in these concentrates were below the manufacturing specifications. The recall status is ongoing. Affected quantity: 19646 cases.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Nov 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19646 cases

Product description

NaturaLyte Liquid Acid concentrate bottles, Model Number 08-3251-9 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reason for recall

The sodium and/or calcium levels in these concentrates were below the manufacturing specifications.

Distribution pattern

US Nationwide distribution.

Code information

Lot Numbers: 20LXAC043 20LXAC044 20LXAC045 20LXAC059 20LXAC060 20LXAC079 20LXAC095 20NXAC026 Additional lots as of 3/17/21: 20LXAC078 20NXAC012 20LXAC058 20LXAC096 20NXAC011

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0820-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0820-2021. Report a data issue: hello@regdatalab.com.